Portfolio news 0

Avacta Group plc

Subscription to raise £2 million

Diurnal Ltd

Diurnal's European Marketing Authorisation Application for Chronocort® passes validation stage with EMA

DeepVerge plc

Increase in Orders for Reagent Consumables

Tissue Regenix Group plc

Update in relation to working capital position and impact of COVID-19 pandemic

Diurnal Ltd

US licencing agreement with Eton Pharmaceuticals for Alkindi® Sprinkle

Xeros Technology Group plc

Former C&A Chief Innovation Officer to Advise Xeros Technology Group on Commercialisation of its Apparel Technologies

Intelligent Ultrasound Group plc

Unaudited Preliminary Results for the Year Ended 31 December 2019

Interim results for the six months ended 31 January 2020

Intelligent Ultrasound Group plc

COVID-19 update and launch of new COVID-19 training simulator

Carisma Therapeutics Inc

First-of-its-kind Engineered Macrophage Cell Therapy Platform Shows Ability to Reduce Tumor Burden and Activate Anti-Tumor Immunity, Improving Overall Survival in Pre-Clinical Cancer Models